ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation

G. Chen, Z. Wu, C. Wang, X. Liu, Q. Li, L. Chen

Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Meeting: 2020 American Transplant Congress

Abstract number: A-019

Keywords: Antibodies, Kidney transplantation, Outcome, Rejection

Session Information

Session Name: Poster Session A: Kidney Acute Antibody Mediated Rejection

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Antibody-mediated rejection(AMR) is a major risk factor for graft loss after kidney transplantation. Some AMR appeared within 6 months after kidney transplant, that we called early AMR. Some AMR appeared after 6 months, that we called late AMR. The aim of this study was to compare the differences of clinical characteristics and outcomes between early AMR and late AMR.

*Methods: We retrospectively collected 32 early AMR patients and 48 late AMR patients who were diagnosed by biopsy in our hospital from January 2011 to December 2018. The clinical characteristics such as age, gender, HLA mismatches, PRA levels before transplant, PRA levels on diagnosis, serum creatinine, proteinuria, hematuria, BANFF criteria for biopsy, induction therapy, and immunosuppressive regimen were all recorded. These characteristics and graft survival were compared between early AMR group and late AMR group.

*Results: Serum creatinine on diagnosis were much higher in early AMR group compared to late AMR group(324±156 vs. 213±112 μmol/L, p<0.05). 24-hours proteinuria on diagnosis was also much higher in early AMR group(1.8±0.9 vs. 1.3±0.7g/L, p<0.05). Preformed DSAs were seen more frequently in early AMR group, while de novo DSAs were seen more frequently in late AMR group. In BANFF criteria, g and ptc grade were much higher in early AMR group, while cg and ci grade were much higher in late AMR group. More early AMR were combined with T cell mediate rejection than late AMR(53.1% vs. 27.0%, p<0.05). Response to anti-rejection therapy were better in early AMR group compared to late AMR group(81.3% vs. 29.2%, p<0.01). Kaplan-Meier analysis showed that 1-,3-,5-year graft survival were much better in early AMR group compared to late AMR group(p<0.05). There were no differences of hematuria, PRA levels on diagnosis, induction therapy and immunosuppressive regimen between early AMR and late AMR group(p>0.05).

*Conclusions: Although symptoms of rejection were more severe in early AMR than late AMR, the prognosis were better in early AMR compared to late AMR.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Chen G, Wu Z, Wang C, Liu X, Li Q, Chen L. Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/comparison-of-clinical-characteristics-and-outcomes-of-early-antibody-mediated-rejection-and-late-antibody-mediated-rejection-after-kidney-transplantation/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences